Results 151 to 160 of about 29,446 (242)

Hyperglycemia aggravates vitiligo through succinate/SUCNR1-mediated T cell activation. [PDF]

J Clin Invest
Kang P, Chang Y, Wang T, Yi X, Wang Y, Du P, Chen J, Li B, Li S, Shao Z, Chen J, Li C.   +11 more
europepmc   +1 more source

The Role of <i>REL</i> and <i>IL2</i> and Their Polymorphisms in the Pathogenesis of Vitiligo-Exploratory Genetic Association Study. [PDF]

Int J Mol Sci
Kądziela M, Migdalska-Sęk M, Domańska-Senderowska D, Kutwin M, Brzeziańska-Lasota E, Woźniacka A.   +5 more
europepmc   +1 more source

Making the case for azathioprine, methotrexate, and cyclosporine in active vitiligo management. [PDF]

Front Med (Lausanne)
Valle Y, Sigova J, Borodina M, Kayumova LN, Almakaeva LI, Pinegin VB, Lomonosov K.   +6 more
europepmc   +1 more source

A real-world retrospective study of vitiligo associated with immune checkpoint inhibitors based on FAERS and TCGA databases. [PDF]

Medicine (Baltimore)
Ma J, Cai Z, Luo Y, Li X, Li J, Hou M, Zhu D.   +6 more
europepmc   +1 more source

Clinical Importance of Autoantibodies to SOX10 and Lamin A/C as Potential Biomarkers in Sera From Vitiligo Patients. [PDF]

Ann Dermatol
Kim JH, Ju HJ, Yoo DW, Bae JM, Lee S, Lee SC, Kim KH.   +6 more
europepmc   +1 more source

Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review. [PDF]

Front Immunol
Wang T, Zhang X, Wang J, Zhuang K, Wang T.   +4 more
europepmc   +1 more source

A two-stage workflow for vitiligo diagnosis: clinical characteristic classification and large language model (LLM)-based report generation. [PDF]

Front Immunol
He K, Xu T, Feng Y, Lu Y, Wang X, Jiang L, Guo S, He Y, Dai W, Zhang W, Zhang J, Lu H, Huang D, Li S.   +13 more
europepmc   +1 more source

Management of Facial Immune Checkpoint Inhibitor-Induced Vitiligo with Topical Ruxolitinib: Quantitative Assessment Using a Semi-Automatic Tool. [PDF]

Curr Oncol
Breakell T, Neri P, Staats LAN, Kramer R, Berking C, Erdmann M, Hartmann A.   +6 more
europepmc   +1 more source

Quality of life impairment in vitiligo: A comprehensive review of psychosocial and clinical determinants. [PDF]

J Int Med Res
Da Costa AF, Ashkanani H, Ferreira C, Torres T.   +3 more
europepmc   +1 more source

Dissecting age-specific genetic architecture of vitiligo through integrative Post-GWAS analysis. [PDF]

Front Immunol
Si Q, Wang S, Chen J, Feng Y, Zhao R, Sun D.   +5 more
europepmc   +1 more source